Research Article

Availability and Access to Medications for Puberty Induction and Maintenance in Adolescents with Hypogonadism in the Arab Region

Table 2

Available estradiol, progesterone, and combined pills preparations within countries and centers. (G) indicates government centers.

MedicineNo. of centers (G)No. of countriesWhich countries

Conjugated estrogen29 (26)10Algeria, Libya, Sudan, UAE, KSA, Iraq, Kuwait, Oman, Jordan, Qatar
Ethinylestradiol26 (24)11Algeria, Egypt, Sudan, Palestine, Jordan, Iraq, Qatar, Oman, uae, KSA, Kuwait
Estrified estrogen15 (13)8Tunisia, Algeria, Iraq, Jordan, KSA, Oman, UAE, Kuwait
17 β estradiol11 (8)6Algeria, Sudan, Tunisia, Iraq, UAE, Palestine
Depot estadiol11 (11)5Iraq, Qatar, Egypt, Jordan, Kuwait
Transdermal estradiol patches10 (9)8KSA, Oman, Iraq, Palestine, Egypt, Algeria, Lebanon, KSA
Estradiol gel6 (4)4Algeria, Iraq, Oman, KSA
Combined pills (OCP)32 (30)9Algeria, Egypt, Iraq, KSA, Oman, Kuwait, Qatar, UAE, Sudan
Oral: Norethisterone22 (21)8Egypt, Sudan, Libya, Iraq, Jordan, KSA, UAE, Oman,
Utrogestan8 (6)3Algeria, Tunisia, UAE
Medroxy progesterone24 (22)7Egypt, Sudan, Iraq, KSA, Oman, UAE, Kuwait
Combined patches8 (2)5Iraq, Palestine, Algeria, Oman, KSA